- Home
- HCKT vs STRO Comparison
HCKT vs STRO Comparison
Compare HCKT & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HCKT | STRO |
|---|---|---|
| Founded | 1991 | 2003 |
| Country | United States | United States |
| Employees | N/A | 131 |
| Industry | Professional Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 392.0M | 338.9M |
| IPO Year | 1998 | N/A |
Fundamental Metrics
Financial Performance| Metric | HCKT | STRO |
|---|---|---|
| Price | $13.31 | $23.78 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 8 |
| Target Price | $17.00 | ★ $26.38 |
| AVG Volume (30 Days) | ★ 275.5K | 170.2K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.72% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.46 | N/A |
| Revenue | ★ $285,862,000.00 | N/A |
| Revenue This Year | $2.55 | N/A |
| Revenue Next Year | $5.07 | $13.45 |
| P/E Ratio | $28.07 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.19 | $0.52 |
| 52 Week High | $28.13 | $27.96 |
Technical Indicators
Market Signals| Indicator | HCKT | STRO |
|---|---|---|
| Relative Strength Index (RSI) | 44.95 | 56.60 |
| Support Level | $12.76 | $0.76 |
| Resistance Level | $14.87 | $27.96 |
| Average True Range (ATR) | 0.52 | 2.12 |
| MACD | 0.10 | -0.13 |
| Stochastic Oscillator | 59.12 | 63.58 |
Price Performance
Historical ComparisonAbout HCKT Hackett Group Inc (The).
The Hackett Group Inc is an IP platform-based Generative Artificial Intelligence (Gen AI) strategic consulting and executive advisory digital transformation firm. The Hackett Group provides dedicated expertise in Gen AI-enabled enterprise transformation services across the front, mid and back office areas, including its highly recognized Oracle, SAP, OneStream and Coupa implementation offerings. It operates in three segments Oracle Solutions, SAP Solutions, and Global S&BT. It generates the majority of its revenue from the Global S&BT segment in the United States.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.